These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29402895)

  • 21. Expression of signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 in urothelial carcinoma.
    Huang WT; Yang SF; Wu CC; Chen WT; Huang YC; Su YC; Chai CY
    Kaohsiung J Med Sci; 2009 Dec; 25(12):640-6. PubMed ID: 19951849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations leading to constitutive active gp130/JAK1/STAT3 pathway.
    Pilati C; Zucman-Rossi J
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):499-506. PubMed ID: 26188635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
    Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
    Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers.
    Bahrenberg G; Behrmann I; Barthel A; Hekerman P; Heinrich PC; Joost HG; Becker W
    Mol Endocrinol; 2002 Apr; 16(4):859-72. PubMed ID: 11923481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An RNA biding protein, Y14 interacts with and modulates STAT3 activation.
    Ohbayashi N; Taira N; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
    Biochem Biophys Res Commun; 2008 Aug; 372(3):475-9. PubMed ID: 18503751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signal transducer and activator of transcription 3 activation by the delta-opioid receptor via Galpha14 involves multiple intermediates.
    Lo RK; Wong YH
    Mol Pharmacol; 2004 Jun; 65(6):1427-39. PubMed ID: 15155836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the linker domain affect phospho-STAT3 function and suggest targets for interrupting STAT3 activity.
    Mertens C; Haripal B; Klinge S; Darnell JE
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14811-6. PubMed ID: 26553978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docosahexaenoic acid inhibits Helicobacter pylori-induced STAT3 phosphorylation through activation of PPARĪ³.
    Ji HG; Piao JY; Kim SJ; Kim DH; Lee HN; Na HK; Surh YJ
    Mol Nutr Food Res; 2016 Jun; 60(6):1448-57. PubMed ID: 27079734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3.
    Biener E; Martin C; Daniel N; Frank SJ; Centonze VE; Herman B; Djiane J; Gertler A
    Endocrinology; 2003 Aug; 144(8):3532-40. PubMed ID: 12865335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway.
    Lee JH; Suk J; Park J; Kim SB; Kwak SS; Kim JW; Lee CH; Byun B; Ahn JK; Joe CO
    Mol Cancer Res; 2009 Oct; 7(10):1663-71. PubMed ID: 19808903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allosteric Communication across STAT3 Domains Associated with STAT3 Function and Disease-Causing Mutation.
    Namanja AT; Wang J; Buettner R; Colson L; Chen Y
    J Mol Biol; 2016 Feb; 428(3):579-589. PubMed ID: 26774853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: relevance to activation of p42/44 mitogen-activated protein kinase.
    Weng YI; Aroor AR; Shukla SD
    Alcohol; 2008 Aug; 42(5):397-406. PubMed ID: 18411006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer.
    Zhang J; Sikka S; Siveen KS; Lee JH; Um JY; Kumar AP; Chinnathambi A; Alharbi SA; Basappa ; Rangappa KS; Sethi G; Ahn KS
    Apoptosis; 2017 Jan; 22(1):158-168. PubMed ID: 27900636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ECHS1 interacts with STAT3 and negatively regulates STAT3 signaling.
    Chang Y; Wang SX; Wang YB; Zhou J; Li WH; Wang N; Fang DF; Li HY; Li AL; Zhang XM; Zhang WN
    FEBS Lett; 2013 Mar; 587(6):607-13. PubMed ID: 23416296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
    Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
    Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
    Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
    Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan LC; Shiau CW; Tai WT; Hung MH; Chu PY; Hsieh FS; Lin H; Yu HC; Chen KF
    Oncogene; 2015 Oct; 34(41):5252-63. PubMed ID: 25619838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.
    Vultur A; Cao J; Arulanandam R; Turkson J; Jove R; Greer P; Craig A; Elliott B; Raptis L
    Oncogene; 2004 Apr; 23(15):2600-16. PubMed ID: 15007380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.